In silico prediction of post-translational modifications in therapeutic antibodies
Monoclonal antibodies are susceptible to chemical and enzymatic modifications during manufacturing, storage, and shipping. Deamidation, isomerization, and oxidation can compromise the potency, efficacy, and safety of therapeutic antibodies. Recently, in silico tools have been used to identify liable...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2022-12-01
|
Series: | mAbs |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/19420862.2021.2023938 |